Hillstream BioPharma (HILS) Insider Trading & Ownership $1.13 +0.03 (+2.72%) As of 04/17/2025 Add Compare Share Share Insider Trades Stock AnalysisChartCompetitorsInsider TradesSEC FilingsTrendsBuy This Stock Hillstream BioPharma (NASDAQ:HILS) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage30.24%Number OfInsiders Buying(Last 3 Years)1Amount OfInsider Buying(Last 3 Years)$2,790.94Number OfInsiders Selling(Last 3 Years)0 Get HILS Insider Trade Alerts Want to know when executives and insiders are buying or selling Hillstream BioPharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address HILS Insider Buying and Selling by Quarter Hillstream BioPharma Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails6/17/2022Randy MilbyCEOBuy500$0.78$390.00 6/6/2022Randy MilbyCEOBuy1,000$0.69$690.00 6/1/2022Randy MilbyCEOBuy1$0.94$0.94 5/25/2022Randy MilbyCEOBuy1,000$0.79$790.00 5/20/2022Randy MilbyCEOBuy1,000$0.92$920.00 (Data available from 1/1/2013 forward) HILS Insider Trading Activity - Frequently Asked Questions Who is on Hillstream BioPharma's Insider Roster? The list of insiders at Hillstream BioPharma includes Randy Milby. Learn more on insiders at HILS. What percentage of Hillstream BioPharma stock is owned by insiders? 30.24% of Hillstream BioPharma stock is owned by insiders. Learn more on HILS's insider holdings. Hillstream BioPharma Key ExecutivesMr. Randy D. Milby MBA (Age 69)Pres, Chairman & CEO Compensation: $471.94kMr. Sireesh Appajosyula Pharm.D. (Age 47)COO & Director Compensation: $64.96kMr. Thomas P. Hess CPA (Age 59)MBA, Chief Financial Officer More Insider Trading Tools from MarketBeat Related Companies Seres Therapeutics Insider Ownership Atossa Therapeutics Insider Ownership MacroGenics Insider Ownership Ventyx Biosciences Insider Ownership Aerovate Therapeutics Insider Ownership Veru Insider Ownership IGM Biosciences Insider Ownership Context Therapeutics Insider Ownership Exicure Insider Ownership Assembly Biosciences Insider Ownership Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Beware of BigBear.ai: Insiders Are Selling—Should You?XPO Buying $50 Million of Its Own Stock: Here's Why Top 3 Large Cap Stocks Insiders Bought in Q1: Buy, Sell, or HoldJoby Aviation: Operational Momentum vs. Market SentimentMicroStrategy Sees Insider Buy-Sell Action in Q1 This page (NASDAQ:HILS) was last updated on 4/22/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | Sponsored‘Wheels Are Falling Off’ the U.S. Stock MarketThe last time the U.S. economy looked like this, stocks didn't move for 16 years... And many investors lost...Stansberry Research | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredMusk's warning signal: Prepare before the cascade beginsWhen Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t...InvestorPlace | SponsoredBiggest AI gains still ahead…? (Major announcement coming)You’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | SponsoredTrade War Just Turned 3 Unknown Stocks Into Rocket FuelThe Real Catalyst Behind America’s Next Bull Run One overlooked sector is being completely repriced — and s...Insiders Exposed | SponsoredTrump’s Top Secret $9 Trillion AI SuperweaponJeff Brown spotted Nvidia at $1. Now he’s revealing a new AI superweapon — and the Musk-connected stocks that ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hillstream BioPharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Hillstream BioPharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy HILS Stock Free HILS Stock Alerts